Application 040797
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 200MG | No | No |
| 002 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 400MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55111-640 | Meprobamate | Meprobamate | Dr.Reddy's Laboratories Limited | ANDA | Current |
| 55111-641 | Meprobamate | Meprobamate | Dr.Reddy's Laboratories Limited | ANDA | Current |
| 69097-974 | Meprobamate | Meprobamate | Cipla USA Inc. | ANDA | Current |
| 69097-975 | Meprobamate | Meprobamate | Cipla USA Inc. | ANDA | Current |